Skip to main content

Tucatinib

(too-KA-tih-nib)

This page contains brief information about tucatinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Tukysa
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Tucatinib is approved to be used with trastuzumab and capecitabine to treat adults with:

Tucatinib is also being studied in the treatment of other types of cancer.

More About Tucatinib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

For Metastatic HER2-Positive Breast Cancer, New Treatments Emerge

Clinical Trials Accepting Patients

Find Clinical Trials for Tucatinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: